HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immunosuppressive therapy for autoimmune inner ear disease.

Abstract
Autoimmune inner ear disease (AIED) is a rare disease that is diagnosed after clinical suspicion and response to corticosteroids. AIED manifests as progressive, bilateral, although often asynchronous, sensorineural hearing loss and can be associated with vestibular symptoms. Since its description as a defined disease entity in 1979, the initial mainstay of treatment remains high-dose corticosteroids. Several animal models have been developed to assist in determining efficacy of immunosuppression in AIED, and several clinical studies have also investigated the role of both steroid and steroid-sparing treatments. Here we discuss the basic science and clinical research surrounding the history of immunosuppressive therapy in AIED.
AuthorsMaria C Buniel, Katie Geelan-Hansen, Peter C Weber, Vincent K Tuohy
JournalImmunotherapy (Immunotherapy) Vol. 1 Issue 3 Pg. 425-34 (May 2009) ISSN: 1750-7448 [Electronic] England
PMID19885385 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Review)
Chemical References
  • Adrenal Cortex Hormones
  • Immunosuppressive Agents
Topics
  • Adrenal Cortex Hormones (therapeutic use)
  • Autoimmune Diseases (drug therapy, immunology, physiopathology)
  • Biomedical Research
  • Hearing Loss, Sensorineural
  • Humans
  • Immunosuppressive Agents (therapeutic use)
  • Labyrinth Diseases (drug therapy, immunology, physiopathology)
  • Models, Animal

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: